The program will support greater accessibility and affordability for clients and enable therapists to share data and experiences among colleagues to increase the efficiency and effectiveness of Psychedelic-assisted Therapy. CALGARY, AB, Sept. 23, 2021 /CNW/ – ATMA Journey Centers Inc. (“ATMA”), an Alberta-based company focused on delivering innovative psychedelic-assisted therapies internationally…


Previous articleMINDCURE Signs Exclusive Digital Clinical Data Licensing Agreement with ATMA Journey Centers
Next articleMindMed and Liechti Lab Provide Results from their Psilocybin R&D Collaboration